Article Figures & Data
Figures
- Figure 1.
Primary End Point in the Intention-to-Treat Population
aOne-sided 97.5% Farrington-Manning upper confidence bound.
UCB, upper confidence bound.
Reproduced with permission from DJ Kereiakes, MD.
- Figure 2.
Primary End Point in the Per-Protocol Population
aOne-sided 97.5% Farrington-Manning upper confidence bound.
UCB, upper confidence bound.
Reproduced with permission from DJ Kereiakes, MD.
Tools
SYNERGY Everolimus-Eluting Stent Noninferior to PROMUS Element Plus: Results from EVOLVE II Randomized Clinical Trial
Permalink:
Table of contents
Cited By...
- No citing articles found.